Measuring, analyzing, and managing drug adherence in resistant hypertension.
about
Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsA comprehensive review of an unmet public health issue: resistant hypertension.Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims data.Patient-Centered Home Care Using Digital Medicine and Telemetric Data for Hypertension: Feasibility and Acceptability of Objective Ambulatory Assessment.The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trialRegulation of renin secretion and arterial pressure during prolonged baroreflex activation: influence of salt intakeNew drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations.Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?Hypertension and Health Behaviors in Females Across the Lifespan.African Americans' Perceptions of Adherence to Medications and Lifestyle Changes Prescribed to Treat Hypertension.Management of Hypertensive Patients With Multiple Drug Intolerances: A Single-Center Experience of a Novel Treatment Algorithm.State-of-the-art treatment of hypertension: established and new drugs.Drug adherence in chronic kidney diseases and dialysis.Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence.Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.Antihypertensive Combination Treatment: State of the Art.Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension.Resistant hypertension: what the cardiologist needs to know.Blood Pressure Out of the Office: Its Time Has Finally Come.Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysisResults of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension.Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.Understanding Medication Nonadherence after Kidney Transplant.Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues.Hypertension in Chronic Kidney Disease.Management of Hypertension in Patients with Chronic Kidney Disease.Detecting non-adherence by urine analysis in patients with uncontrolled hypertension: rates, reasons and reactions.Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic.7th Brazilian Guideline of Arterial Hypertension: Chapter 13 - Resistant Arterial HypertensionEffect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study.Effect of Cardiac-Cycle-Synchronized Selective Vagal Stimulation on Heart Rate and Blood Pressure in Rats.Heart rate is a useful marker of adherence to beta-blocker treatment in hypertension.Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?Influence of Clonidine on Antihypertensive Selective Afferent Vagal Nerve Stimulation in Rats.Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
P2860
Q26741084-E69C9405-8451-4A88-9493-E017E41CC7DAQ26777871-2FD1A459-643A-4040-A766-1A7263B603B7Q30235310-376C6221-D156-4F81-81DD-1D2B478DC530Q30250362-8D28404A-5CB9-4684-B648-F727D982EE38Q30701410-AAC6172D-379F-40CC-9AD7-39F3C9A67E94Q31047495-8915D4A0-E1EA-4F17-84AB-71E9A5855162Q33916917-EF0D7156-6CF5-473A-B16A-0BA46A271257Q34046925-356147C5-B299-4107-808B-28C943A2F06CQ34384580-10509413-BC5D-4AF3-8CF7-F4680B9C518FQ35231679-6F334B16-3E4C-480F-AE19-35C145F23AFFQ35770395-978CB2D0-B5B2-4CBC-81B0-408EA52E9EF9Q36190964-5A663A40-33CC-48F3-A6F6-F0BA84426C04Q36858259-4C92AFB2-1EEB-4BB9-98C1-D4BF8969B013Q37309094-4D5EC09C-EED3-4863-9D0B-C6122096B7D1Q38161696-9FBF0EDB-FF5A-4A42-BF6C-9530347BE2DAQ38187107-C20D298F-D3E9-4D1E-BD32-2F0E5A3B9151Q38236473-B55AA790-02F6-4834-880C-5BA903683EA2Q38492034-BEE1A032-9601-4632-AED8-26A515FC4950Q38525960-C7FD22C2-12F9-4CD8-936F-49E5ED7C5F9BQ38545377-4ADEFB18-402F-4029-A5AC-4664B441B87AQ38564177-F63E6299-979D-4A54-A466-A11C5EC1371AQ38627661-2E059A35-379F-4AA5-A27B-BA42363252FAQ38631156-28205631-8365-4304-A2FA-A765AF8D45A7Q38685633-B65F542F-7A24-4D94-AE2A-0823BE5C4E87Q38686369-CE4BBAA8-803F-43E9-978C-C832ACFB4539Q38718380-B0145E89-3745-4483-AC53-9ED2AF12F0D9Q38819507-57FD5D1B-BFD7-4AAE-A941-10010A3F0581Q39081841-34167CD2-6434-45D3-AA4A-C5F3A4227A1DQ39165623-062004A0-5FD6-4142-A6BA-C8C3508416AFQ39268835-DDD8E198-52F4-458A-84FB-BAE4867B1C97Q39389583-F17E78A8-5150-4507-84F5-AF626A9FDF8AQ40969129-ACDC1F8D-906B-4B4B-B243-587004FD4B2FQ42320532-361B8EF4-30C6-42EB-8A41-6881AF5460A8Q46638114-9A8CBDFD-FBD6-4C0B-A238-472DD607D94EQ47427126-DE0DEDA6-C781-4878-90E8-B89D1C6480DFQ48137409-E169E3CC-5AB1-4913-B49B-BC642FACCFD2Q49628031-1ACE5B1C-18D2-496D-AC38-295AB8B9DBA2Q50725209-0B876AE5-33EB-4246-B7B2-20E7E2A5565FQ51277955-8BDD63AA-A4DC-400B-BD51-F3BCDC81BA49Q53676374-9A92D025-1F93-4188-8C16-1ED8CAC2947A
P2860
Measuring, analyzing, and managing drug adherence in resistant hypertension.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Measuring, analyzing, and managing drug adherence in resistant hypertension.
@en
type
label
Measuring, analyzing, and managing drug adherence in resistant hypertension.
@en
prefLabel
Measuring, analyzing, and managing drug adherence in resistant hypertension.
@en
P2093
P1433
P1476
Measuring, analyzing, and managing drug adherence in resistant hypertension.
@en
P2093
Gregoire Wuerzner
Harry Struijker-Boudier
John Urquhart
Michel Burnier
P304
P356
10.1161/HYPERTENSIONAHA.113.00687
P407
P577
2013-06-10T00:00:00Z